The collaboration will also use Astellas’ universal donor cell and gene editing technology it obtained through its $102m acquisition of Universal Cells in 2018. Adaptimmune has already been ...

Alltrna’s CEO Michelle Warner said that the approach allows for basket trials that can group patients with different diseases ...

Universal Cells brought leading gene editing capability to make targeted gene edits to modify the characteristics of selected iPSC cell lines, and Adaptimmune the technology to differentiate iPSCs ...

CAMBRIDGE, Mass., Feb. 28, 2025 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to ...

On track to report initial data from Phase 1/2 clinical trial of PM359 for p47phox CGD in 2025 -- -- IND-enabling studies ongoing for PM577 for Wilson's Disease; expect to file IND and/or CTA in ...

On this episode of Fortune’s Leadership Next podcast, co-hosts Diane Brady, executive editorial director of the Fortune CEO Initiative and Fortune Live Media, and editorial director Kristin Stoller ...

Broadway and Hollywood have always had a symbiotic relationship, borrowing from each other liberally since the advent of film ...

Vertex has backed out of its in vivo gene editing collaboration with Verve Therapeuti | Vertex has backed out of its in vivo ...

Artificial intelligence is making waves across industries, but its impact is higher in some sectors than others. Medicine and other sciences stand to gain much from this technology, thanks to their ...

A vast search of natural diversity has led scientists at MIT's McGovern Institute and the Broad Institute of MIT and Harvard ...

Could it also give us better tomatoes, a hybrid woolly mammoth-elephant that could help save Arctic forests, and perhaps even ...

The animals are the first to have been created by Colossal Biosciences, and have fluffy coats and curly whiskers.